Jiawen Wang is a distinguished surgeon and deputy chief physician at a leading hospital specializing in Traditional Chinese Medicine, with a focused expertise in colorectal surgery and integrative medicine. She has made significant contributions to the clinical management of anorectal disorders and inflammatory bowel disease, combining traditional Chinese medicine approaches with minimally invasive surgical and endoscopic interventional techniques. As a principal investigator and key researcher in multiple competitive research projects, she has led studies that bridge traditional practices with modern medical science, investigating clinical outcomes and underlying biological mechanisms. Her scholarly output includes numerous peer-reviewed publications, contributions to books, and active participation as a reviewer for several academic journals. Her work has garnered recognition through multiple awards and patents, reflecting innovation and clinical impact. Collaborating with prominent institutions both nationally and internationally, she has advanced the application of integrative medicine in gastroenterology and pelvic floor medicine. She is also actively involved in professional societies, holding leadership and committee roles that influence clinical standards, research priorities, and training programs in colorectal and integrative medicine. Her contributions are characterized by the integration of traditional methodologies with evidence-based research, promoting high standards in both clinical practice and academic scholarship. She has achieved a total of 116 citations, with 112 citations since 2020, an h-index of 4 overall and since 2020, and an i10-index of 2 both total and since 2020, reflecting the recognition and influence of her work within the scientific and medical community. Her research and clinical practice demonstrate a unique capacity to combine innovation, rigorous scientific validation, and practical applicability, establishing her as a leading figure in the advancement of integrative approaches to colorectal and gastrointestinal medicine.
Profile: Orcid | Google Scholar
Featured Publications
1. Wang, J. W., Pan, Y. B., Cao, Y. Q., Wang, C., Jiang, W. D., Zhai, W. F., & Lu, J. G. (2020). Loganin alleviates LPS‐activated intestinal epithelial inflammation by regulating TLR4/NF‐κB and JAK/STAT3 signaling pathways. The Kaohsiung Journal of Medical Sciences, 36(4), 257–264.
2. Wang, J., Pan, Y., Cao, Y., Zhou, W., & Lu, J. (2019). Salidroside regulates the expressions of IL-6 and defensins in LPS-activated intestinal epithelial cells through NF-κB/MAPK and STAT3 pathways. Iranian Journal of Basic Medical Sciences, 22(1), 31.
3. Jiang, X., Chen, X., Dong, R., Wang, J., Pan, Y., & Cao, Y. (2023). Establishment of a mouse model of inflammatory bowel disease using dextran sulfate sodium. Advances in Clinical and Experimental Medicine, 32(5), 563–573.
4. Luo, Q., Wang, J., Ge, W., Li, Z., Mao, Y., Wang, C., & Zhang, L. (2024). Exploration of the potential causative genes for inflammatory bowel disease: Transcriptome-wide association analysis, Mendelian randomization analysis and Bayesian colocalisation. Heliyon, 10(7), [Article 7].
5. Liao, W., Luo, Q., Zhang, L., Wang, H., Ge, W., Wang, J., & Zuo, Z. (2024). Genetic overlap between inflammatory bowel disease and iridocyclitis: Insights from a genome-wide association study in a European population. BMC Genomic Data, 25(1), 92.